Fermi is trading 4.3% down now at $4.75 amid broad risk-off pressure and biotechnology stocks down 4.24%.

  • The Nasdaq is down 0.70%; September 1 weakness reflects renewed inflation and geopolitical concerns, including higher oil prices and rising bond yields.
  • No September 1 company-specific announcement was identified; the latest major update was the previously reported TensorWave agreement and convertible-notes financing.
  • The decline follows recent volatility after August 13 results: zero quarterly revenue, a $25.8 million net loss, despite progress on Project Matador.